Free Trial

MeiraGTx (MGTX) Competitors

MeiraGTx logo
$8.37 +0.30 (+3.72%)
Closing price 04:00 PM Eastern
Extended Trading
$8.34 -0.03 (-0.42%)
As of 04:36 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MGTX vs. VCEL, NAMS, DNLI, KNSA, RXRX, APGE, CGON, AGIO, INDV, and IRON

Should you be buying MeiraGTx stock or one of its competitors? The main competitors of MeiraGTx include Vericel (VCEL), NewAmsterdam Pharma (NAMS), Denali Therapeutics (DNLI), Kiniksa Pharmaceuticals International (KNSA), Recursion Pharmaceuticals (RXRX), Apogee Therapeutics (APGE), CG Oncology (CGON), Agios Pharmaceuticals (AGIO), Indivior (INDV), and Disc Medicine (IRON). These companies are all part of the "pharmaceutical products" industry.

MeiraGTx vs. Its Competitors

Vericel (NASDAQ:VCEL) and MeiraGTx (NASDAQ:MGTX) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, profitability, analyst recommendations, media sentiment, earnings and valuation.

Vericel currently has a consensus price target of $61.14, indicating a potential upside of 47.33%. MeiraGTx has a consensus price target of $24.00, indicating a potential upside of 186.74%. Given MeiraGTx's higher probable upside, analysts clearly believe MeiraGTx is more favorable than Vericel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vericel
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
3.00
MeiraGTx
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

Vericel has higher revenue and earnings than MeiraGTx. MeiraGTx is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Vericel$237.22M8.81$10.36M$0.031,383.33
MeiraGTx$33.28M20.21-$147.79M-$2.32-3.61

Vericel has a beta of 1.32, suggesting that its stock price is 32% more volatile than the S&P 500. Comparatively, MeiraGTx has a beta of 1.24, suggesting that its stock price is 24% more volatile than the S&P 500.

67.5% of MeiraGTx shares are owned by institutional investors. 5.2% of Vericel shares are owned by company insiders. Comparatively, 7.5% of MeiraGTx shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Vericel has a net margin of 1.25% compared to MeiraGTx's net margin of -484.90%. Vericel's return on equity of 1.09% beat MeiraGTx's return on equity.

Company Net Margins Return on Equity Return on Assets
Vericel1.25% 1.09% 0.73%
MeiraGTx -484.90%-241.05%-62.93%

In the previous week, MeiraGTx had 6 more articles in the media than Vericel. MarketBeat recorded 8 mentions for MeiraGTx and 2 mentions for Vericel. Vericel's average media sentiment score of 0.92 beat MeiraGTx's score of 0.50 indicating that Vericel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Vericel
1 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
MeiraGTx
3 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

Vericel beats MeiraGTx on 10 of the 15 factors compared between the two stocks.

Get MeiraGTx News Delivered to You Automatically

Sign up to receive the latest news and ratings for MGTX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MGTX vs. The Competition

MetricMeiraGTxMED IndustryMedical SectorNASDAQ Exchange
Market Cap$648.55M$2.90B$5.50B$8.96B
Dividend YieldN/A2.44%5.25%4.02%
P/E Ratio-3.617.8219.9019.84
Price / Sales20.21295.68436.90127.27
Price / CashN/A41.8337.0657.97
Price / Book9.627.868.125.62
Net Income-$147.79M-$54.95M$3.16B$248.50M
7 Day Performance20.95%6.24%4.40%5.54%
1 Month Performance32.44%5.70%4.09%7.52%
1 Year Performance107.69%8.08%34.53%22.06%

MeiraGTx Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MGTX
MeiraGTx
4.4219 of 5 stars
$8.37
+3.7%
$24.00
+186.7%
+97.3%$648.55M$33.28M-3.61300News Coverage
Insider Trade
High Trading Volume
VCEL
Vericel
2.9345 of 5 stars
$42.55
+2.0%
$61.14
+43.7%
-14.4%$2.10B$237.22M1,418.81300
NAMS
NewAmsterdam Pharma
2.2774 of 5 stars
$18.11
-2.5%
$42.89
+136.8%
+0.1%$2.08B$45.56M-9.634Positive News
DNLI
Denali Therapeutics
4.5856 of 5 stars
$13.99
-0.8%
$33.71
+141.0%
-32.4%$2.05B$330.53M-5.24430News Coverage
Analyst Revision
KNSA
Kiniksa Pharmaceuticals International
3.5553 of 5 stars
$27.67
-1.3%
$38.80
+40.2%
+37.0%$2.05B$423.24M-110.68220Analyst Upgrade
RXRX
Recursion Pharmaceuticals
1.9534 of 5 stars
$5.06
+0.6%
$7.00
+38.3%
-27.6%$2.04B$58.84M-2.86400Trending News
Analyst Forecast
Options Volume
APGE
Apogee Therapeutics
2.8818 of 5 stars
$43.43
+0.1%
$94.60
+117.8%
-8.1%$2.00BN/A-12.0691News Coverage
Analyst Forecast
Options Volume
High Trading Volume
CGON
CG Oncology
2.3606 of 5 stars
$26.00
+0.2%
$58.67
+125.6%
-19.0%$1.98B$1.14M-17.2261
AGIO
Agios Pharmaceuticals
4.0684 of 5 stars
$33.26
-0.6%
$58.60
+76.2%
-11.9%$1.94B$36.50M2.96390
INDV
Indivior
3.2722 of 5 stars
$14.74
+5.7%
$17.00
+15.3%
-1.1%$1.92B$1.19B-47.551,051High Trading Volume
IRON
Disc Medicine
3.1624 of 5 stars
$52.96
-2.8%
$96.70
+82.6%
+11.5%$1.89BN/A-13.5130Positive News
Insider Trade

Related Companies and Tools


This page (NASDAQ:MGTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners